
Leadership
Sector
Medical Devices
Acclarent develops minimally invasive ENT devices, including balloon sinuplasty for chronic sinusitis, and was acquired by Ethicon (J&J) in 2010.

Their story
.avif)
.avif)
.avif)


Acclarent develops minimally invasive ENT devices, including balloon sinuplasty for chronic sinusitis, and was acquired by Ethicon (J&J) in 2010.